Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Şerife Solmaz Medeni"'
Publikováno v:
European Journal of Rhinology and Allergy, Vol 3, Iss 3, Pp 69-71 (2020)
Externí odkaz:
https://doaj.org/article/e47316b7c1cb43079c4bdd9e21d1b298
Autor:
Şerife Solmaz Medeni, Doğus Türkyılmaz, Celal Acar, Ömür Gökmen Sevindik, Faize Yüksel, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, İnci Alacacıoğlu, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Objective: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred to achieve engraftment. Some
Externí odkaz:
https://doaj.org/article/3903f33454c340b9bbc990d2d2e4c0d0
Autor:
Sinan Demircioğlu, Abdullah Karakuş, Mahmut Töbü, Senem Altay Dadin, Orhan Ayyildiz, Mehmet Ali Erkurt, Naile Guner, Osman Özcebe, Omur Gokmen Sevindik, Fatih Demirkan, Emine Gültürk, Ismail Sari, Sevgi Kalayoglu Besisik, Mehmet Sönmez, İlhami Kiki, Erdal Kurtoğlu, Anil Tombak, Gülsüm Özet, Turgay Ulas, Demet Kiper Ünal, Nermin Kutlu, Mutlu Arat, Deniz Goren Sahin, Halil Celik, Simten Dagdas, Cengiz Demir, Bahriye Payzin, Sibel Hacioglu, Filiz Vural, Fevzi Altuntaş, Serdal Korkmaz, Zahit Bolaman, Özgür Meletli, Volkan Karakuş, Serkan Ocakci, Murat Albayrak, Ilker Bay, Hava Üsküdar Teke, Irfan Kuku, Ilhami Berber, Tulay Karaagac Akyol, Berna Afacan Öztürk, Mehmet Sinan Dal, Şerife Solmaz Medeni, Gulsum Akgun Cagliyan, Seckin Cagirgan, Gökhan Özgür, Düzgün Özatlı, Mehmet Hilmi Dogu
Publikováno v:
Transfusion and Apheresis Science. 58:287-292
Karakus, Volkan/0000-0001-9178-2850; Demirkan, Fatih/0000-0002-1172-8668; Demircioglu, Sinan/0000-0003-1277-5105; Arat, Mutlu/0000-0003-2039-8557; Cagliyan, Gulsum Akgun/0000-0002-2073-1949; Ozturk, Hacer Berna Afacan/0000-0001-9386-7604; WOS: 000473
Publikováno v:
Pamukkale Medical Journal. 10:67-72
Autor:
Erhan Tatar, Şerife Solmaz Medeni, Sinem Namdaroglu, Zehra Hilal Adibelli, Can Ozlu, Funda Tasli, Tugba Cetintepe, Oktay Bilgir
Publikováno v:
Hematology Reports
Hematology Reports, Vol 10, Iss 3 (2018)
Hematology Reports, Vol 10, Iss 3 (2018)
Atypical hemolytic uremic syndrome is a rare and progressive disease caused by uncontrolled alternative complement activation. Dysregulatıon of the complement activation results in thrombotic microangiopathy and multiorgan damage. A 29-yearold woman
Autor:
Omur Gokmen Sevindik, Fatih Demirkan, Inci Alacacioglu, Mehmet Ali Özcan, Doğuş Türkyılmaz, Celal Acar, Güner Hayri Özsan, Şerife Solmaz Medeni, Faize Yuksel, Bülent Ündar, Özden Pişkin
Publikováno v:
Turkish Journal of Hematology
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Objective High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred to achieve engraftment. Some p
Autor:
Mehmet Ali Özcan, Ahmet Seyhanli, Fatih Demirkan, Özden Pişkin, Alev Acar, Emin Taşkıran, Şerife Solmaz Medeni, Güner Hayri Özsan, Inci Alacacioglu, Ömür Gökmen Sevindik, Celal Acar, Bülent Ündar, Aybüke Olgun
Publikováno v:
Clinical transplantation. 32(9)
WOS: 000445328900014 PubMed ID: 30053318 Background: Recent reports have showed that neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and monocyte-to-lymphocyte ratio (MLR) are predictors of progression-free survival (PFS) an
Autor:
Mehmet Ali Özcan, Şerife Solmaz Medeni, Fusun Ozdemirkan, Güner Hayri Özsan, Özden Pişkin, Fatih Demirkan, Inci Alacacioglu, Bülent Ündar, Abdullah Katgi, O Gokmen Sevindik, Celal Acar, Bahriye Payzin
Multiple induction regimens have been developed for adult patients with acute lymphoblastic leukemia (ALL). However, there have been no prospective randomized trials that directly compare these regimens. In this study, we wanted to evaluate the outco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b440d3646ac17e4b971ce25a43bb1bc1
https://avesis.deu.edu.tr/publication/details/58ab1f71-1eed-4387-b717-f8d41e529091/oai
https://avesis.deu.edu.tr/publication/details/58ab1f71-1eed-4387-b717-f8d41e529091/oai
Autor:
H. Ozsan, Muhit Ozcan, Abdullah Katgi, Ömür Gökmen Sevindik, Inci Alacacioglu, C. Acar, Özden Pişkin, Şerife Solmaz Medeni, B. Undar, S. Kahraman, Z.G. Güç, Fatih Demirkan
Publikováno v:
Leukemia Research. 39:S123
Autor:
F. Özdemirkıran, Ö. Pişkin, Kadriye Bahriye Payzin, Fatih Demirkan, İnci Alacacioğlu, Celal Acar, Mert Özcan, Hayri Özsan, F. Demirkan, Inci Alacacioglu, C. Acar, Omur Gokmen Sevindik, Mehmet Ali Özcan, K. B. Payzın, Fusun Ozdemirkiran, Şerife Solmaz Medeni, Ömür Gökmen Sevindik, Süreyya Yiğit Kaya, S. Yiğit Kaya, D. Türkyılmaz, Özden Pişkin, Doğuş Türkyılmaz, H. G. Özsan
Publikováno v:
Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi. 28:139
Amac: Klasik olarak kronik intravaskuler hemoliz bulgulari, kemik iligi yetersizligi ve trombozla kendini gosteren Paroksismal Nokturnal Hemoglobinuri (PNH), hematopoietik kok hucrenin klonal bir hastaligidir. Eculizimab ise PNH tedavisinde hemolizi